Specimens were weighed in the field on a set of 0.1 g precision scales and sacrificed with Citanest
(3%) immediately afterwards.
Local anaesthetic agents used were therapeutic formulations of bupivacaine 0.5% (Bupivacaine, Pfizer, West Ryde, Australia), lignocaine 1% (Xylocaine, AstraZeneca, North Ryde, Australia), prilocaine 0.5% (Citanest
, AstraZeneca, North Ryde, Australia), and ropivacaine 0.5% (Naropin, AstraZeneca, North Ryde, Australia).
Aspiration was performed before the administration of the local anesthetic solution and the application of various nerve blocks with different solutions were successful in all the patients who underwent local anesthesia with 3.6 mL of two percent lidocaine with 1:80.000 epinephrine ([Jetokain.sup.R], Adeka), 3.6 mL of two percent lidocaine without a vasoconstrictor (Jetokain [Simplex.sup.R], Adeka) and 3.6 mL of three percent prilocaine with 0.03 IU (international units)/mL octa-pressin (Citanest
[Octapressin.sup.R], Astra Zeneca).
Local anaesthetic solutions such as lidocaine (Xylocaine) and prilocaine (Citanest
) mixed with epinephrine are safe for procedures when dosed appropriately.22 Sedatives such as benzodiazepines (e.g., midazolam), lorazepam (Ativan) and triazolam (Halcion) should be avoided.
Local anesthetics are given by injection or topically, and include benzocaine, bupivacaine (Marcaine, Sensorcaine), chloroprocaine (Nesacaine), camphor, dibucaine (Nuper-cainal), levobupivacaine (Chirocaine), lidocaine (Xylocaine, Octocaine), mepivacaine (Carbocaine, Polocaine), pramoxine, prilocaine (Citanest
), procaine (Novocaine), ropivacaine (Naropin), and tetracaine (Pontocaine).
A randomized trial of citanest
with octapressin for relief of pain associated with laser vaporization of the cervix.
Brief summary of prescribing information: Citanest
Plain[R] and Citanest[R] Forte [Package insert].
18 September 2017 - UK-based drugmaker AstraZeneca (NYSE: AZN) has entered into an agreement with Mauritius-based Aspen Group's Aspen Global Inc business under which AGI will now acquire the residual rights to the established anaesthetic medicines comprising of Diprivan, EMLA,Xylocaine/Xylocard/Xyloproct, Marcaine, Naropin, Carbocaine and Citanest
, the company said.